ZNF383
gene geneOn this page
Also known as FLJ35863Zfp383
Summary
ZNF383 (zinc finger protein 383, HGNC:18609) is a protein-coding gene on chromosome 19q13.13, encoding Zinc finger protein 383 (Q8NA42). May function as a transcriptional repressor, suppressing transcriptional activities mediated by MAPK signaling pathways.
The protein encoded by this gene is a KRAB-related zinc finger protein that inhibits the transcription of some MAPK signaling pathway genes. The repressor activity resides in the KRAB domain of the encoded protein.
Source: NCBI Gene 163087 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 60 total
- MANE Select transcript:
NM_001387601
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18609 |
| Approved symbol | ZNF383 |
| Name | zinc finger protein 383 |
| Location | 19q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ35863, Zfp383 |
| Ensembl gene | ENSG00000188283 |
| Ensembl biotype | protein_coding |
| OMIM | 619499 |
| Entrez | 163087 |
Gene structure
Transcript identifiers
Ensembl transcripts: 20 — 16 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000352998, ENST00000585441, ENST00000586068, ENST00000586658, ENST00000588250, ENST00000588371, ENST00000589413, ENST00000590503, ENST00000684119, ENST00000882182, ENST00000882183, ENST00000938216, ENST00000938217, ENST00000938218, ENST00000938219, ENST00000938220, ENST00000938221, ENST00000952120, ENST00000952121, ENST00000952122
RefSeq mRNA: 14 — MANE Select: NM_001387601
NM_001345947, NM_001345948, NM_001345949, NM_001387593, NM_001387594, NM_001387595, NM_001387596, NM_001387597, NM_001387598, NM_001387599, NM_001387600, NM_001387601, NM_001387602, NM_152604
CCDS: CCDS12501
Canonical transcript exons
ENST00000684119 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002435646 | 37235549 | 37235675 |
| ENSE00002820334 | 37224818 | 37224939 |
| ENSE00003500339 | 37230409 | 37230462 |
| ENSE00003690165 | 37235979 | 37236074 |
| ENSE00003917444 | 37218214 | 37218274 |
| ENSE00003917887 | 37242469 | 37248740 |
Expression profiles
Bgee: expression breadth ubiquitous, 188 present calls, max score 82.05.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.7395 / max 71.7681, expressed in 1453 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175542 | 3.1858 | 1335 |
| 175541 | 0.5536 | 320 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 82.05 | gold quality |
| calcaneal tendon | UBERON:0003701 | 81.76 | gold quality |
| colonic epithelium | UBERON:0000397 | 81.74 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 80.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.00 | gold quality |
| bone marrow cell | CL:0002092 | 79.29 | gold quality |
| muscle of leg | UBERON:0001383 | 78.68 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.63 | gold quality |
| gastrocnemius | UBERON:0001388 | 78.49 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 77.38 | gold quality |
| cortical plate | UBERON:0005343 | 77.19 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.84 | gold quality |
| leukocyte | CL:0000738 | 76.56 | gold quality |
| stromal cell of endometrium | CL:0002255 | 76.26 | gold quality |
| ventricular zone | UBERON:0003053 | 76.15 | gold quality |
| monocyte | CL:0000576 | 76.03 | gold quality |
| mucosa of stomach | UBERON:0001199 | 75.94 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 75.69 | gold quality |
| islet of Langerhans | UBERON:0000006 | 75.63 | gold quality |
| rectum | UBERON:0001052 | 75.33 | gold quality |
| popliteal artery | UBERON:0002250 | 75.03 | gold quality |
| tibial artery | UBERON:0007610 | 75.03 | gold quality |
| skin of leg | UBERON:0001511 | 74.69 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.69 | gold quality |
| left ovary | UBERON:0002119 | 74.61 | gold quality |
| skin of abdomen | UBERON:0001416 | 74.41 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 74.30 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 74.11 | gold quality |
| aorta | UBERON:0000947 | 74.08 | gold quality |
| endocervix | UBERON:0000458 | 74.00 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 23.15 |
| E-ANND-3 | no | 5.92 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| JUN | Repression |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA1979.1 | ZNF416 | More than 3 adjacent zinc fingers |
| MA1979.2 | ZNF416 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:25690854
Literature-anchored findings (GeneRIF, showing 2)
- Overexpression of ZNF383 in cells inhibits the transcriptional activities of AP-1 and SRE, suggesting that ZNF383 may act as a negative regulator in MAPK-mediated signaling pathways. (PMID:15964543)
- 19q13.12 KRAB zinc-finger protein ZNF383 represses p53 signaling pathway by interacting with p53. (PMID:35835334)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp383 | ENSMUSG00000099689 |
| rattus_norvegicus | Zfp420 | ENSRNOG00000020774 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 383 — Q8NA42 (reviewed: Q8NA42)
All UniProt accessions (3): Q8NA42, K7EJN0, K7ELW4
UniProt curated annotations — full annotation on UniProt →
Function. May function as a transcriptional repressor, suppressing transcriptional activities mediated by MAPK signaling pathways.
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Expressed in heart, placenta, liver, pancreas and with a higher level in skeletal muscle.
Domain organisation. The KRAB domain is responsible for the transcriptional repressor activity.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (14): NP_001332876, NP_001332877, NP_001332878, NP_001374522, NP_001374523, NP_001374524, NP_001374525, NP_001374526, NP_001374527, NP_001374528, NP_001374529, NP_001374530, NP_001374531, NP_689817 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050826 | Krueppel_C2H2_ZnFinger | Family |
Pfam: PF00096, PF01352, PF13465
UniProt features (16 total): zinc finger region 11, sequence conflict 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NA42-F1 | 73.36 | 0.30 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 62 (showing top):
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_MEMBRANE, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOCC_ORGANELLE_ENVELOPE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, IRF5_TARGET_GENES, NCOA2_TARGET_GENES, NFE2L1_TARGET_GENES, RYBP_TARGET_GENES, ZBTB12_TARGET_GENES, ZBTB18_TARGET_GENES, ZNF33A_TARGET_GENES, ZNF391_TARGET_GENES, ZNF618_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): nucleoplasm (GO:0005654), cytoplasm (GO:0005737), nuclear membrane (GO:0031965), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| cellular anatomical structure | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| nuclear lumen | 1 |
| intracellular anatomical structure | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
882 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF383 | CEP170 | Q5SW79 | 446 |
| ZNF383 | USP6 | P35125 | 418 |
| ZNF383 | TMBIM6 | P55061 | 391 |
| ZNF383 | YPEL3 | P61236 | 387 |
| ZNF383 | ACOT13 | Q9NPJ3 | 383 |
| ZNF383 | PCMT1 | P22061 | 379 |
| ZNF383 | UGGT2 | Q9NYU1 | 377 |
| ZNF383 | PARS2 | Q7L3T8 | 371 |
| ZNF383 | EMG1 | Q92979 | 371 |
| ZNF383 | TDP2 | O95551 | 366 |
| ZNF383 | BAG4 | O95429 | 364 |
| ZNF383 | RPL6 | Q02878 | 363 |
| ZNF383 | ZNF326 | Q5BKZ1 | 362 |
| ZNF383 | HSPA8 | P11142 | 354 |
| ZNF383 | NEK7 | Q8TDX7 | 353 |
| ZNF383 | PHB2 | Q99623 | 353 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF572 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLE5 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF383 | ZIM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF383 | RCOR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOL4 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM28 | ZNF320 | psi-mi:“MI:0914”(association) | 0.530 |
| EWSR1 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.370 |
| ZNF383 | ZNF195 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC7A9 | CDC7 | psi-mi:“MI:0914”(association) | 0.350 |
| NRAS | IGKV2D-24 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF572 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TLE5 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZIM2 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.000 |
| RCOR3 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NOL4 | ZNF383 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (21): ZNF383 (Affinity Capture-RNA), ZNF383 (Two-hybrid), ZNF383 (Two-hybrid), ZNF383 (Two-hybrid), ZNF383 (Two-hybrid), ZIM2 (Two-hybrid), LRP4 (Affinity Capture-MS), ZNF195 (Affinity Capture-MS), ZNF644 (Affinity Capture-MS), LRP5 (Affinity Capture-MS), TRIM39 (Affinity Capture-MS), IKBIP (Affinity Capture-MS), LRP6 (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), UBR1 (Affinity Capture-MS)
ESM2 similar proteins: A2RRD8, A6NHJ4, B4DX44, O75346, P10077, P10755, P15621, P16372, P16373, P51786, P52737, P85977, Q0VGE8, Q14588, Q147U1, Q15928, Q15973, Q2M3X9, Q3KNS6, Q3MIS6, Q494X3, Q5HY98, Q5RBQ3, Q5REK1, Q5VIY5, Q60585, Q61751, Q6GQR8, Q7L2R6, Q7TSH9, Q8IYX0, Q8N782, Q8N823, Q8N988, Q8N9F8, Q8NA42, Q8NCK3, Q8NDP4, Q8NEP9, Q8TC21
Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
60 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1046 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:37227991:G:GT | donor_gain | 1.0000 |
| 19:37230461:AGG:A | donor_loss | 1.0000 |
| 19:37230463:G:GC | donor_loss | 1.0000 |
| 19:37230464:T:A | donor_loss | 1.0000 |
| 19:37232725:A:T | donor_gain | 1.0000 |
| 19:37235545:TCA:T | acceptor_loss | 1.0000 |
| 19:37235546:CAG:C | acceptor_loss | 1.0000 |
| 19:37235547:A:AG | acceptor_gain | 1.0000 |
| 19:37235547:A:G | acceptor_loss | 1.0000 |
| 19:37235547:AG:A | acceptor_gain | 1.0000 |
| 19:37235547:AGG:A | acceptor_gain | 1.0000 |
| 19:37235548:G:GC | acceptor_gain | 1.0000 |
| 19:37235548:GG:G | acceptor_gain | 1.0000 |
| 19:37235548:GGG:G | acceptor_gain | 1.0000 |
| 19:37235672:ATGGG:A | donor_loss | 1.0000 |
| 19:37235673:TGGGT:T | donor_loss | 1.0000 |
| 19:37235674:GG:G | donor_gain | 1.0000 |
| 19:37235675:GG:G | donor_gain | 1.0000 |
| 19:37235675:GGTAA:G | donor_loss | 1.0000 |
| 19:37235676:G:GG | donor_gain | 1.0000 |
| 19:37235676:G:GT | donor_loss | 1.0000 |
| 19:37235677:TAAG:T | donor_loss | 1.0000 |
| 19:37218272:CAGG:C | donor_loss | 0.9900 |
| 19:37218275:G:C | donor_loss | 0.9900 |
| 19:37218276:T:A | donor_loss | 0.9900 |
| 19:37235541:T:TA | acceptor_gain | 0.9900 |
| 19:37235548:GGGAT:G | acceptor_gain | 0.9900 |
| 19:37242467:A:AG | acceptor_gain | 0.9900 |
| 19:37242468:G:GG | acceptor_gain | 0.9900 |
| 19:37230460:GAG:G | donor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000051839 (19:37220425 T>C,G), RS1000083133 (19:37244820 T>C), RS1000159617 (19:37220967 A>G), RS1000324243 (19:37233215 C>G,T), RS1000351940 (19:37227345 C>T), RS1000423178 (19:37233782 T>C), RS1000511620 (19:37221206 A>G), RS1000578243 (19:37239346 A>G), RS1000640417 (19:37237375 GA>G,GAA), RS1001090729 (19:37244888 TTTCATG>T), RS1001121747 (19:37222588 G>A), RS1001225507 (19:37245578 G>A,T), RS1001468987 (19:37235091 G>A), RS1001530673 (19:37241278 C>T), RS1001544908 (19:37244637 C>T)
Disease associations
OMIM: gene MIM:619499 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002097_45 | Coronary artery calcification | 7.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004723 | coronary artery calcification |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | increases expression, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| trichostatin A | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cupric oxide | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic Trioxide | affects cotreatment, decreases expression | 1 |
| Antimycin A | increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Camptothecin | increases expression | 1 |
| Cytarabine | increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tretinoin | affects cotreatment, decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | increases expression, affects cotreatment | 1 |
| Cyclosporine | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.